IMNMImmunome, Inc.
$19.36+20% 1Y
$19.36
$15.2452 weeks$29.84
The business
How IMNM's business earns
- Share count, year on year
- +29%
Share count, year on year · more shares than a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2023 | −781% |
| FY2024 | −3382% |
| FY2025 | −3229% |
Details›
- Revenue, trailing twelve months
- $0
- Free cash flow, trailing twelve months
- −$239M
- Net income, trailing twelve months
- −$283M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry